Click to view your profile
Click to search for condition or expert
Click to open main menu
Transverse Myelitis Latest Advances
Find the Latest Research About Transverse Myelitis
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 05/05/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 158 publications
See more filters
Successful treatment of rituximab-unresponsive elderly-onset neuromyelitis optica spectrum disorder and hypogammaglobulinemia with ofatumumab plus intravenous immunoglobulin therapy in a patient with mutant FCGR3A genotype: A case report.
Condition:
Elderly-Onset Neuromyelitis Optica Spectrum Disorder (NMOSD) with Mutant FCGR3A Genotype
Journal:
Frontiers in immunology
Treatment Used:
Ofatumumab Plus Intravenous Immunoglobulin Therapy
Number of Patients:
1
Published:
December 26, 2022
VIEW PUBLICATION
A Novel approach using O-CVP to treat paraneoplastic NMO spectrum disorder associated with follicular lymphoma.
Condition:
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal:
BMJ case reports
Treatment Used:
Obinutuzumab, Cyclophosphamide, Vincristine and Prednisolone (O-CVP)
Number of Patients:
1
Published:
November 15, 2022
VIEW PUBLICATION
Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic review.
Condition:
Aquaporin-4 IgG Neuromyelitis Optica Spectrum Disorder (NMOSD) After COVID-19 Vaccination
Journal:
Journal of neuroimmunology
Treatment Used:
Steroids
Number of Patients:
16
Published:
November 04, 2022
VIEW PUBLICATION
MRI-negative myelitis associated with cerebral venous thrombosis after COVID-19 infection.
Condition:
Transverse Myelitis and Cerebral Venous Thrombosis After COVID-19
Journal:
BMJ case reports
Treatment Used:
Anticoagulation and Steroids
Number of Patients:
1
Published:
October 28, 2022
VIEW PUBLICATION
Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.
Condition:
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders (MOGADs)
Journal:
Journal of neurology, neurosurgery, and psychiatry
Treatment Used:
Rituximab
Number of Patients:
315
Published:
October 25, 2022
VIEW PUBLICATION
Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease.
Condition:
Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody Disease (MOGAD)
Journal:
Neurology
Treatment Used:
Rituximab
Number of Patients:
111
Published:
October 14, 2022
VIEW PUBLICATION
New Treatment Perspectives for Acute Relapses in Neuromyelitis Optica Spectrum Disorder.
Condition:
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal:
Transfusion medicine reviews
Treatment Used:
Corticosteroids, Therapeutic Plasma Exchange, and Targeted Therapies
Number of Patients:
0
Published:
September 24, 2022
VIEW PUBLICATION
A meta-analysis on efficacy and safety of rituximab for neuromyelitis optica spectrum disorders.
Condition:
Neuromyelitis Optica Spectrum Disorders (NMOSDs)
Journal:
Medicine
Treatment Used:
Rituximab
Number of Patients:
681
Published:
September 10, 2022
VIEW PUBLICATION
Autologous hematopoietic stem cell transplantation in neuromyelitis optica spectrum disorder: A systematic review and meta-analysis.
Condition:
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Treatment Used:
Autologous Hematopoietic Stem Cell Transplantation (AHSCT)
Number of Patients:
39
Published:
September 08, 2022
VIEW PUBLICATION
Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder.
Condition:
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal:
CNS drugs
Treatment Used:
Inebilizumab
Number of Patients:
0
Published:
September 07, 2022
VIEW PUBLICATION
Pediatric therapeutic options in autoimmune neurologic diseases.
Condition:
Pediatric Autoimmune Neurological Diseases
Journal:
Medicina
Treatment Used:
Steroids, Immunoglobulin, or Plasmapheresis
Number of Patients:
0
Published:
September 02, 2022
VIEW PUBLICATION
Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar.
Condition:
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Journal:
Multiple sclerosis and related disorders
Treatment Used:
Satralizumab
Number of Patients:
83
Published:
August 25, 2022
VIEW PUBLICATION
Showing 1-12 of 158
Next
Last Updated: 05/05/2023